Please click here to get the updated version of In-Vitro Diagnostic (IVD) Market (Applications, End-users & Types) Trends & Global Forecasts (Major & Emerging Markets – G7, Japan & BRIC) (2011 - 2016)

The IVD markets of BRIC economies offer immense growth opportunities due to the increasing healthcare budgets in these nations, along with the increasing number of private corporate hospitals, and the rising income levels backed by a huge, untapped population bases. Despite regulatory hurdles and other restraints such as low consumer awareness and the absence of regulations concerning patient safety, the BRIC IVD market is expected to grow from $2.9 billion in 2009 to $7.2 billion-$7.5 billion in 2014 at a CAGR of ~19%-20% from 2009 to 2014. In comparison, the growth rate of the global IVD market is pegged at only ~5%-6% in the next five years. Our research indicates that China is expected to command the largest IVD market among all BRIC economies.

Scope of the Report

This report categorizes the BRIC IVD market on the basis of:
Geography: Brazil, Russia, India and China
Diagnostic Services: Hematology, immunology, microbiology, molecular diagnostics, urine analysis, etc.

Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 50 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 20 company profiles for each of its sub-segments.

What makes our reports unique?

• We provide accurate business intelligence within the markets we study.
• Each report is not only a representation of facts but a discussion of the markets we study. This we believe gives the reader on-ground information about the markets within diverse geographies.
• The markets are studied through research interviews conducted with industry participants across the respective geographies. The study includes analytics over the data received for faster decision making.
• We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

TABLE OF CONTENTS
 
EXECUTIVE SUMMARY 
BRIC IVD market overview

1 INTRODUCTION
  1.1 Key take-aways
  1.2 Report description
  1.3 Stakeholders
  1.4 Research methodology & key assumptions
  1.5 Market segmentation and definitions

2 SUMMARY

3 OVERVIEW OF THE GLOBAL IVD MARKET
  3.1 Market perspective

4 IVD MARKET OVERVIEW-BRAZIL
  4.1 Scope
  4.2 Drivers
  4.3 Restraints
  4.4 Trends
  4.5 Market Size
  4.6 Competitive landscape
  4.7 Market forecast
  4.8 Regulatory body: Anvisa

5 IVD MARKET BY SEGMENTS -BRAZIL
  5.1 Hematology
      5.1.1 Market size and forecast
      5.1.2 Competitive landscape
  5.2 Biochemistry
      5.2.1 Market size and forecast
      5.2.2 Competitive landscape
  5.3 Immunology
      5.3.1 Market size and forecast
      5.3.2 Competitive landscape
  5.4 Molecular diagnostics
      5.4.1 Market size and forecast
      5.4.2 Competitive landscape
  5.5 Microbiology
      5.5.1 Market size and forecast
      5.5.2 Competitive landscape
  5.6 Hemostasis
      5.6.1 Market size and forecast
      5.6.2 Competitive landscape
  5.7 Cytology
      5.7.1 Market size and forecast
      5.7.2 Competitive landscape
  5.8 Cardiac markers
      5.8.1 Market size and forecast
      5.8.2 Competitive landscape
  5.9 Hormones/marking tumors
      5.9.1 Market size and forecast
      5.9.2 Competitive landscape

6 IVD MARKET OVERVIEW- RUSSIA
  6.1 Market scope
  6.2 Drivers
  6.3 Restraints
  6.4 Trends
  6.5 Market Size
  6.6 Competitive landscape
  6.7 Market forecast
  6.8 Regulatory body

7 IVD MARKET BY SEGMENTS - RUSSIA
  7.1 Hemotology
      7.1.1 Market size and forecast
      7.1.2 Competitive landscape
  7.2 Biochemistry
      7.2.1 Market size and forecast
      7.2.2 Competitive landscape
  7.3 Immunology
      7.3.1 Market size and forecast
      7.3.2 Competitive landscape
  7.4 Molecular diagnostics
      7.4.1 Market size and forecast
      7.4.2 Competitive landscape
  7.5 Microbiology
      7.5.1 Market size and forecast
      7.5.2 Competitive landscape
 
8 IVD MARKET OVERVIEW - INDIA
  8.1 Market scope
  8.2 Drivers
  8.3 Restraints
  8.4 Trends
  8.5 Market size
  8.6 Competitive landscape
  8.7 Market forecast
  8.8 Regulations for diagnostic equipments in India

9 IVD MARKET BY SEGMENTS - INDIA
  9.1 Hematology
      9.1.1 Market size and forecast
      9.1.2 Competitive landscape
  9.2 Biochemistry
      9.2.1 Market size and forecast
      9.2.2 Competitive landscape
  9.3 Immunology
      9.3.1 Market size and forecast
      9.3.2 Competitive landscape
  9.4 Molecular diagnostics
      9.4.1 Market size and forecast
      9.4.2 Competitive landscape
  9.5 Urinalysis
      9.5.1 Market size and forecast
      9.5.2 Competitive landscape
 
10 IVD MARKET OVERVIEW - CHINA
   10.1 Market scope
   10.2 Drivers
   10.3 Restraints
   10.4 Trends
   10.5 Market size
   10.6 Competitive landscape
   10.7 Market forecast
   10.8 Regulation process for medical devices

11 IVD MARKET BY SEGMENTS - CHINA
   11.1 Hematology
        11.1.1 Market size and forecast
        11.1.2 Competitive landscape
   11.2 Biochemistry
        11.2.1 Market size and forecast
        11.2.2 Competitive landscape
   11.3 Immunology
        11.3.1 Market size and forecast
        11.3.2 Competitive landscape
   11.4 Molecular diagnostics
        11.4.1 Market size and forecast
        11.4.2 Competitive landscape
   11.5 Microbiology
        11.5.1 Market size and forecast
        11.5.2 Competitive landscape
 
12 COMPETITIVE LANDSCAPE
   12.1 Mergers & acquisitions in IVD market

13 COMPANY PROFILES
   13.1 ABBOTT DIAGNOSTICS
   13.2 BECKMAN COULTER INC
   13.3 BECTON, DICKINSON & CO.
   13.4 BIOMΙRIEUX SA
   13.5 BIO-RAD LABORATORIES INC
   13.6 DIASORIN DIAGNOSTICS SPA
   13.7 HORIBA LTD.
   13.8 MINDRAY LTD
   13.9 ORTHO-CLINICAL DIAGNOSTICS INC
   13.10 OXOID LTD
   13.11 QIAGEN N.V
   13.12 ROCHE DIAGNOSTICS LTD
   13.13 SIEMENS HEALTHCARE
   13.14 SYSMEX CORP

APPENDIX 
Global IVD Patents  
  
LIST OF TABLES 
 
Summary BRIC IVD Market 2007 – 2014 ($Millions)
1 IVD market size of top ten countries (2008)
2 Brazil IVD: market forecast by segments 2007 – 2014 ($Millions)
3 Russia ageing population
4 Russia IVD: market forecast by segments 2007 – 2014 ($Millions)
5 India IVD: market forecasts by segments 2007-2014 ($Millions)
6 China IVD: market forecast 2007-2014 ($Millions)
7 New product launches in IVD market (2009 – 2010 March)
8 Mergers & acquisitions in IVD market (2008 – 2009)
  
LIST OF FIGURES 
 
1 Brazil IVD market share
2 Brazil IVD: market revenue 2007 – 2014 ($Millions)
3 Brazil hematology: market forecast 2007 – 2014 ($Millions)
4 Brazil hematology: competitive landscape (2009)
5 Brazil biochemistry: market forecast 2007 – 2014 ($Millions)
6 Brazil biochemistry: competitive landscape (2009)
7 Brazil immunology: market forecast 2007 – 2014 ($Millions)
8 Brazil immunology: competitive landscape
9 Brazil molecular diagnostics: market forecast 2007 – 2014 ($Millions)
10 Brazil molecular diagnostics: competitive landscape
11 Brazil microbiology: market forecast 2007 – 2014 ($Millions)
12 Brazil microbiology: competitive landscape (2009)
13 Brazil hemostasis: market forecast 2007 – 2014 ($Millions)
14 Brazil hemostasis: competitive landscape (2009)
15 Brazil cytology: market forecast 2007 – 2014 ($Millions)
16 Brazil cytology: competitive landscape (2009)
17 Brazil cardiac markers: market forecast 2007 – 2014 ($Millions)
18 Brazil cardiac markers: competitive landscape (2009)
19 Brazil hormones: market forecast 2007 – 2014 ($Millions)
20 Brazil hormones: competitive landscape (2009)
21 Russia IVD: competitive landscape (2009)
22 Russia IVD: market forecast 2007 – 2014 ($Millions)
23 Russia hematology: market forecast 2007 – 2014 ($Millions)
24 Russia hematology: competitive landscape (2009)
25 Russia biochemistry: market forecast 2007 – 2014 ($Millions)
26 Russia biochemistry: competitive landscape (2009)
27 Russia immunology: market forecast 2007 – 2014 ($Millions)
28 Russia immunology: competitive landscape (2009)
29 Russia molecular diagnostics: market forecast 2007 – 2014 ($Millions)
30 Russia molecular diagnostics: competitive landscape (2009)
31 Russia microbiology: market forecast 2007 – 2014 ($Millions)
32 Russia microbiology: competitive landscape (2009)
33 Literacy in India: percentage of total population
34 Percentage of the total population by age
35 Urban middle class household in India: percentage of total by income
36 Mortality rate in India: percentage of total by diseases type (1990 – 2020)
37 Number of policies by type of coverage in millions, (2007)
38 Total household consumption: percentage of total by various segments, (1985 – 2025)
39 Market shares of different segments (2009)
40 India IVD: growth rate of different segments (2009)
41 Indian IVD market competitive landscape (2009)
42 India IVD: market forecast 2007 – 2014 ($Millions)
43 India hematology: market forecast 2007 – 2014 ($Millions)
44 Indian hematology market competitive landscape (2009)
45 India biochemistry: market forecast 2007 – 2014 ($Millions)
46 India biochemistry: competitive landscape (2009)
47 India immunology: market forecast 2007 – 2014  ($Millions)
48 India immunology: competitive landscape (2009)
49 India molecular diagnostic: market forecast 2007 – 2014 ($Millions)
50 India molecular diagnostic: competitive landscape (2009)
51 India urinalysis: market forecast 2007 – 2014 ($Millions)
52 India urinalysis: competitive landscape (2009)
53 Market of different segment (2009)
54 China IVD competitive landscape (2009)
55 China IVD: market forecast 2007-2014 ($Millions)
56 Process of device registration
57 China hematology: market forecast 2007-2014 ($Millions)
58 China hematology: competitive landscape (2009)
59 China biochemistry: market forecast 2007-2014 ($Millions)
60 China biochemistry: competitive landscape (2009)
61 China immunology: market forecast 2007-2014 ($Millions)
62 China immunology: competitive landscape (2009)
63 China molecular diagnostic: market forecast 2007-2014 ($Millions)
64 Molecular diagnostics: competitive landscape (2009)
65 China microbiology: market forecast 2007-2014 ($Millions)
66 China microbiology: competitive landscape (2009)
67 Competitive analysis by competitors (2009)